Most Recent
The Full Court is set to weigh in on whether judges who make adverse findings on credibility during the liability phase of a hearing should recuse themselves from determining penalty, an issue which a judge has said may require a new court protocol.
A judge has signed off on a $23.1 million cut for funder Augusta of a $100 million settlement in a class action against Colonial First State, which he previously called "strange" and said may not reflect the risk the funder shared with Slater & Gordon in running the case.
Car park operator Secure Parking has been hit with a $10.95 million penalty for misleading consumers in major cities about its car reservation service, causing them to be late or miss appointments and work commitments entirely.
G&S Engineering and its parent company, DRA Global, can redact what a court has found is privileged information provided in a witness statement by a former top executive, in the latest interlocutory stoush ahead of trial in a high stakes dispute with MACH Energy.
Two judges have declined to award carriage of a class action against International Capital Markets over risky derivative products to a firm accused of plagiarising its rivals' pleading.
The Australian Competition and Consumer Commission has approved France-based Louis Dreyfus' proposed acquisition of ASX-traded cotton gin operator Namoi Cotton, after accepting an undertaking that allayed its competition concerns.
Regional air carrier Rex Airlines has filed for voluntary administration after failing to compete with Qantas and Virgin on major routes.
Swiss fintech Temenos has partially won its bid to view legal advice received by the Northern Inland Credit Union in a lawsuit alleging the cloud banking provider made misleading representations during negotiations for the installation of a new core banking system.
Experts say the chaos of last month’s CrowdStrike outage is likely to spark a flurry of litigation both overseas and at home, including class actions, but lawyers bringing the claims will face significant hurdles.
A law firm is investigating claims against the manufacturers of popular heartburn and acid reflux drugs, alleging they could be responsible for causing stomach cancers and kidney failure in approximately 100,000 people.